We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.00 | 0.77% | 260.80 | 260.40 | 260.60 | 266.40 | 255.80 | 263.20 | 3,596,311 | 16:29:59 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 41.01 | 5.35B |
From May 2021 to May 2024
TIDMCTEC
RNS Number : 3512D
ConvaTec Group PLC
28 June 2021
ConvaTec Director Declaration
Reading, United Kingdom (28 June 2021)
ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Dr Regina Benjamin, Non-Executive Director of the Company, currently serves as a Director of Doximity, Inc. (NYSE: DOCS), which commenced trading on the New York Stock Exchange with effect from 24(th) June 2021.
This announcement is made in accordance with Listing Rule 9.6.14R.
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations +44 (0)7826 447807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane/ Hannah Ratcliff +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com .
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RDNPPUBPQUPGGGR
(END) Dow Jones Newswires
June 28, 2021 07:40 ET (11:40 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
